Patents by Inventor Reshma Chudasama

Reshma Chudasama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compound
    Patent number: 7960551
    Abstract: A succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenylcarbamoyl)ethyl]piperidin-4-yl ester or a solvate thereof, for use in treating pulmonary disorders.
    Type: Grant
    Filed: February 8, 2007
    Date of Patent: June 14, 2011
    Assignee: Glaxo Group Limited
    Inventors: Reshma Chudasama, Andrew Kennedy
  • 1-Benzazepine-3-Sulfonylamino-2-Pyrroridones as Factor Xa Inhibitors
    Publication number: 20080306045
    Abstract: The invention relates to chemical entities of formula (I): and/or pharmaceutically acceptable derivative(s) thereof. The invention also relates to processes for the preparation of compounds of formula (I), pharmaceutical compositions containing compounds of formula (I) and to the use of compounds of formula (I) in medicine, particularly in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: November 22, 2006
    Publication date: December 11, 2008
    Inventors: Laure Camus, Reshma Chudasama, Caroline Jane Day, Deepali Deshmukh, John Gerald Gleason, John David Harling, Chao-Pin Lee, Paula Saklatvala, Stefan Senger, Sarah Vallance, John Watson, Nigel Stephen Watson, Robert John Young, Barbara Yuan
  • Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors
    Publication number: 20080058369
    Abstract: The invention provides N-{[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]methyl}-4-({8-[(2-hydroxyethyl)(methyl)amino]octanoyl}amino)benzamide, whose formula is , or a salt thereof, such as the monohydrochloride salt thereof. The invention also provides the use of the compound or salt as inhibitors of phosphodiesterase type IV (PDE4) and/or for the treatment and/or prophylaxis of inflammatory and/or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, or rhinitis (e.g. allergic and/or non-allergic rhinitis).
    Type: Application
    Filed: July 31, 2007
    Publication date: March 6, 2008
    Inventors: David Allen, Rodger Barnett, Reshma Chudasama, Caroline Day, Christopher Edlin, Leanda Kindon
  • Novel Compound
    Publication number: 20070281971
    Abstract: A succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenylcarbamoyl)ethyl]piperidin-4-yl ester or a solvate thereof, for use in treating pulmonary disorders.
    Type: Application
    Filed: February 8, 2007
    Publication date: December 6, 2007
    Applicant: GLAXO GROUP LIMITED
    Inventors: Reshma Chudasama, Andrew Kennedy